Does inspiratory muscle training provide additional benefits during pulmonary rehabilitation in people with interstitial lung disease? A randomized control trial

Inspiratory muscle training (IMT) has been described as one of the components of the treatment of chronic lung conditions such as obstructive and restrictive lung diseases. Although the number of studies showing results of IMT in patients with interstitial lung disease (ILD) is scarce when compared with studies in patients with COPD, evidence points to benefits of IMT in this population. This scoping review aimed to explore the role and the rationale of IMT in patients with ILD and to gather recent evidence on the effects of IMT in this population. The studies included in this review showed improvements in respiratory muscle function, quality of life, exercise capacity and dyspnea after ILD patients participated in programs that included stand-alone IMT or combined with pulmonary rehabilitation. There is still a gap in the literature to allow a clear conclusion on the indications of IMT as part of ILD treatment because of poor research design and small numbers of participants. Therefore, although IMT seems to have a positive effect in patients with ILD, current evidence prevents us from drawing a definite conclusion. Further studies need to be conducted using better research methodology to demonstrate and confirm the positive effects of IMT.

Download Full-text

Ventilatory Function and Exercise Capacity Response to Inspiratory Muscle Training in Interstitial Lung Disease Patients

The Medical Journal of Cairo University ◽

10.21608/mjcu.2020.125156 ◽

2020 ◽

Vol 88 (12) ◽

pp. 2111-2115

Author(s):

FATMA M. MAHMOUD, M.Ss.; SAMIR A. EL GAZAR, Ph.D. ◽

FATMA ABOELMAGD, Ph.D.; MAHA F.M. SHEHATA, M.D.

Keyword(s):

Interstitial Lung Disease ◽

Lung Disease ◽

Exercise Capacity ◽

Inspiratory Muscle ◽

Inspiratory Muscle Training ◽

Ventilatory Function ◽

Muscle Training

Download Full-text

Randomized Control Trial of Effects of a 10-Week Inspiratory Muscle Training Program on Measures of Pulmonary Function in Persons with Multiple Sclerosis

Journal of Neurologic Physical Therapy ◽

10.1097/npt.0b013e31815ce136 ◽

2007 ◽

Vol 31 (4) ◽

pp. 162-172 ◽

Cited By ~ 55

Author(s):

Donna K. Fry ◽

Lucinda A. Pfalzer ◽

Anang R. Chokshi ◽

Michelle T. Wagner ◽

Emily S. Jackson

Keyword(s):

Multiple Sclerosis ◽

Pulmonary Function ◽

Training Program ◽

Randomized Control Trial ◽

Inspiratory Muscle ◽

Inspiratory Muscle Training ◽

Muscle Training ◽

Randomized Control

Download Full-text

Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial

European Respiratory Journal ◽

10.1183/13993003.02000-2017 ◽

2018 ◽

Vol 51 (1) ◽

pp. 1702000 ◽

Cited By ~ 29

Author(s):

Konrad Schultz ◽

Danijel Jelusic ◽

Michael Wittmann ◽

Benjamin Krämer ◽

Veronika Huber ◽

...

Keyword(s):

Quality Of Life ◽

Pulmonary Rehabilitation ◽

Controlled Trial ◽

Intervention Group ◽

Inspiratory Muscle ◽

Inspiratory Muscle Training ◽

Chronic Obstructive ◽

Muscle Training ◽

Randomised Controlled

The value of inspiratory muscle training (IMT) in pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) is unclear. The RIMTCORE (Routine Inspiratory Muscle Training within COPD Rehabilitation) randomised controlled trial examined the effectiveness of IMT added to pulmonary rehabilitation.In total, 611 COPD patients (Global Initiative for Chronic Obstructive Lung Disease stage II–IV) received a 3-week inpatient pulmonary rehabilitation, of which 602 patients were included in the intention-to-treat analyses. The intervention group (n=300) received highly intensive IMT and the control group (n=302) received sham IMT. The primary outcome was maximal inspiratory pressure (PImax). The secondary outcomes were 6-min walk distance, dyspnoea, quality of life and lung function. Outcomes were assessed pre- and post-pulmonary rehabilitation. ANCOVA was used.The intervention group showed higher effects in PImax (p<0.001) and forced inspiratory volume in 1 s (p=0.013). All other outcomes in both study groups improved significantly, but without further between-group differences. Sex and pulmonary rehabilitation admission shortly after hospitalisation modified quality of life effects.IMT as an add-on to a 3-week pulmonary rehabilitation improves inspiratory muscle strength, but does not provide additional benefits in terms of exercise capacity, quality of life or dyspnoea. A general recommendation for COPD patients to add IMT to a 3-week pulmonary rehabilitation cannot be made.

Download Full-text